We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IMNM market cap is 673M. The company's latest EPS is USD -2.4996 and P/E is -6.29.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 2.36M | 4.26M | 3.57M |
Operating Income | -8.53M | -7.79M | -4.47M | -5.77M | -4.63M |
Net Income | -9.16M | -7.79M | -4.27M | -5.56M | -4.35M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 503k | 0 | 14.02M |
Operating Income | -10.35M | -12.26M | -24.7M | -36.9M | -109.53M |
Net Income | -10.44M | -17.84M | -24.71M | -37.52M | -106.81M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 30.55M | 24.05M | 48.11M | 41.44M | 93.16M |
Total Liabilities | 7.46M | 7.39M | 34.25M | 32.1M | 87.09M |
Total Equity | 23.08M | 16.65M | 13.86M | 9.34M | 6.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 5.06M | 44.53M | 57.93M | 24.05M | 148.54M |
Total Liabilities | 1.8M | 3.18M | 9.74M | 7.39M | 28.66M |
Total Equity | -35.63M | 41.35M | 48.19M | 16.65M | 119.88M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -22.01M | -28.69M | 24.17M | 18.51M | 9.89M |
Investing | -176k | -248k | -106k | -446k | -482k |
Financing | 32k | 32k | 34k | 34k | 60.91M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -9.6M | -12.13M | -18.23M | -28.69M | -7.57M |
Investing | -233k | -586k | -79k | -248k | -30.48M |
Financing | 10.77M | 49.94M | 27.77M | 32k | 116.41M |
Market Cap | 673M |
Price to Earnings Ratio | -6.29 |
Price to Sales Ratio | 47.94 |
Price to Cash Ratio | 6.81 |
Price to Book Ratio | 5.61 |
Dividend Yield | - |
Shares Outstanding | 42.73M |
Average Volume (1 week) | 983.81k |
Average Volume (1 Month) | 838.43k |
52 Week Change | 206.42% |
52 Week High | 30.958 |
52 Week Low | 4.50 |
Spread (Intraday) | 1.02 (6.08%) |
Company Name | Immunome Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.immunome.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions